×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Adjuvant Global Health Technology Fund, L.P.

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerJan 16, 2024Sale$19.6584,0931,652,4271,995,958Jan 18, 2024, 06:18 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerJan 16, 2024Sale$19.6515,907312,573377,542Jan 18, 2024, 06:18 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerNov 14, 2023Sale$16.151,52224,5742,080,051Nov 16, 2023, 06:59 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerNov 14, 2023Sale$16.152884,650393,449Nov 16, 2023, 06:59 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerOct 02, 2023Sale$16.074,77076,6542,081,573Oct 03, 2023, 07:13 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerOct 02, 2023Sale$16.0790214,495393,737Oct 03, 2023, 07:13 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerSep 29, 2023Sale$16.2883,3371,356,7262,086,343Oct 03, 2023, 07:13 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerSep 29, 2023Sale$16.2815,764256,638394,639Oct 03, 2023, 07:13 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerSep 27, 2023Sale$16.071342,153411,759Sep 29, 2023, 05:41 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerSep 28, 2023Sale$16.117,160115,3482,169,680Sep 29, 2023, 05:41 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerSep 28, 2023Sale$16.111,35621,845410,403Sep 29, 2023, 05:41 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerSep 27, 2023Sale$16.0770711,3612,176,840Sep 29, 2023, 05:41 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerSep 13, 2023Sale$16.003365,3762,177,547Sep 15, 2023, 05:17 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerSep 13, 2023Sale$16.00641,024411,893Sep 15, 2023, 05:17 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerSep 07, 2023Sale$16.052,84145,5982,177,883Sep 08, 2023, 04:59 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerSep 07, 2023Sale$16.055378,619411,957Sep 08, 2023, 04:59 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerSep 06, 2023Sale$16.023,16450,6872,180,724Sep 08, 2023, 04:59 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerSep 06, 2023Sale$16.025989,580412,494Sep 08, 2023, 04:59 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerAug 23, 2023Sale$16.003365,3762,183,888Aug 25, 2023, 04:31 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerAug 23, 2023Sale$16.00641,024413,092Aug 25, 2023, 04:31 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerJun 06, 2022Option Exercise$15.0026,511397,6652,184,224Jun 24, 2022, 05:06 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerJun 06, 2022Option Exercise$15.0026,511397,665413,156Jun 24, 2022, 05:06 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerMar 29, 2022Buy$15.00166,6662,499,9902,210,735Jun 24, 2022, 04:51 PM
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P.10% OwnerMar 29, 2022Buy$15.00166,6662,499,9902,210,735Mar 31, 2022, 08:15 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe